166 related articles for article (PubMed ID: 25888278)
1. Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells.
Narayanan S; Mony U; Vijaykumar DK; Koyakutty M; Paul-Prasanth B; Menon D
Nanomedicine; 2015 Aug; 11(6):1399-406. PubMed ID: 25888278
[TBL] [Abstract][Full Text] [Related]
2. Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics.
Narayanan S; Pavithran M; Viswanath A; Narayanan D; Mohan CC; Manzoor K; Menon D
Acta Biomater; 2014 May; 10(5):2112-24. PubMed ID: 24389318
[TBL] [Abstract][Full Text] [Related]
3.
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
[TBL] [Abstract][Full Text] [Related]
4. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
5. High tolerated paclitaxel nano-formulation delivered by poly (lactic-co-glycolic acid)-g-dextran micelles to efficient cancer therapy.
Liu P; Situ JQ; Li WS; Shan CL; You J; Yuan H; Hu FQ; Du YZ
Nanomedicine; 2015 May; 11(4):855-66. PubMed ID: 25725489
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
7. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
Wu J; Zhang J; Deng C; Meng F; Zhong Z
Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
[TBL] [Abstract][Full Text] [Related]
9. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells.
Ramadass SK; Anantharaman NV; Subramanian S; Sivasubramanian S; Madhan B
Colloids Surf B Biointerfaces; 2015 Jan; 125():65-72. PubMed ID: 25437065
[TBL] [Abstract][Full Text] [Related]
11. Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel.
Liu Y; Zhang B; Yan B
Int J Mol Sci; 2011; 12(7):4395-413. PubMed ID: 21845085
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone-releasing hormone peptide tethered nanoparticulate system for enhanced antitumoral efficacy of paclitaxel.
Ghanghoria R; Tekade RK; Mishra AK; Chuttani K; Jain NK
Nanomedicine (Lond); 2016 Apr; 11(7):797-816. PubMed ID: 26980704
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
15. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.
Vicari L; Musumeci T; Giannone I; Adamo L; Conticello C; De Maria R; Pignatello R; Puglisi G; Gulisano M
BMC Cancer; 2008 Jul; 8():212. PubMed ID: 18657273
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
[TBL] [Abstract][Full Text] [Related]
18. A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing.
Malarvizhi GL; Chandran P; Retnakumari AP; Ramachandran R; Gupta N; Nair S; Koyakutty M
Nanomedicine; 2014 Apr; 10(3):579-87. PubMed ID: 24200524
[TBL] [Abstract][Full Text] [Related]
19. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R
Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]